A detailed history of Exome Asset Management LLC transactions in Adagene Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 262,625 shares of ADAG stock, worth $538,381. This represents 0.4% of its overall portfolio holdings.

Number of Shares
262,625
Previous 150,876 74.07%
Holding current value
$538,381
Previous $462 Million 26.24%
% of portfolio
0.4%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.12 - $3.49 $236,907 - $390,004
111,749 Added 74.07%
262,625 $583 Million
Q2 2024

Aug 14, 2024

SELL
$2.12 - $3.24 $9,554 - $14,602
-4,507 Reduced 2.9%
150,876 $462 Million
Q1 2024

May 15, 2024

BUY
$1.96 - $4.15 $304,550 - $644,839
155,383 New
155,383 $435 Million

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $89M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.